Terms: = Kidney tumors AND MUC1, PEM, 4582, ENSG00000185499, PUM, MAM6, EMA, CD227, H23AG
361 results:
1. [Modern view on the problem of diagnostics of renal angiomioadenomatous tumor].
Osmanov Y I; Kogan E A; Gadzhieva Z K; Radenska-Lopovok S G; Prochenko D D
Urologiia; 2024 Mar; (1):92-95. PubMed ID: 38650412
[TBL] [Abstract] [Full Text] [Related]
2. Histomorphometric and Immunohistochemical Diagnosis of Renal Cell Carcinoma: Review Article.
Deka D; Chakravarty M
Mymensingh Med J; 2024 Apr; 33(2):636-642. PubMed ID: 38557550
[TBL] [Abstract] [Full Text] [Related]
3. The Role of muc1 in Renal Cell Carcinoma.
Milella M; Rutigliano M; Lasorsa F; Ferro M; Bianchi R; Fallara G; Crocetto F; Pandolfo SD; Barone B; d'Amati A; Spilotros M; Battaglia M; Ditonno P; Lucarelli G
Biomolecules; 2024 Mar; 14(3):. PubMed ID: 38540735
[TBL] [Abstract] [Full Text] [Related]
4. Biphasic papillary (biphasic squamoid alveolar) renal cell carcinoma: a clinicopathologic and molecular study of 17 renal cell carcinomas including 10 papillary adenomas.
Nova-Camacho LM; Acosta AM; Akgul M; Panizo A; Galea LA; Val-Carreres A; Talavera JA; Guerrero-Setas D; Martin-Arruti M; Ruiz I; García-Martos M; Sangoi AR
Virchows Arch; 2024 Mar; 484(3):441-449. PubMed ID: 38388964
[TBL] [Abstract] [Full Text] [Related]
5. Sarcomatoid variant of Xp11 translocation renal cell carcinoma: A rare case report in an adult female.
Jagdale RV; Jain S; Pol JN; Khochikar MV
Indian J Pathol Microbiol; 2024; 67(1):178-181. PubMed ID: 38358216
[TBL] [Abstract] [Full Text] [Related]
6. Dendritic cell vaccination in combination with erlotinib in a patient with inoperable lung adenocarcinoma: a case report.
Kosumi T; Kobayashi M; Shimodaira S; Sugiyama H; Koido S
J Med Case Rep; 2024 Feb; 18(1):88. PubMed ID: 38336778
[TBL] [Abstract] [Full Text] [Related]
7. Mucin-1-Targeted Chimeric Antigen Receptor T Cells Are Effective and Safe in Controlling Solid tumors in Immunocompetent Host.
Zhou R; Wu ST; Yazdanifar M; Williams C; Sanders A; Brouwer C; Maher J; Mukherjee P
J Immunother; 2024 Apr; 47(3):77-88. PubMed ID: 38270462
[TBL] [Abstract] [Full Text] [Related]
8. Low grade oncocytic renal tumor (LOT): Clinicopathological characterization of 13 cases.
Almutairi F; Xu B
Pathol Res Pract; 2024 Feb; 254():155127. PubMed ID: 38241777
[TBL] [Abstract] [Full Text] [Related]
9. [Clinicopathological features of intravascular large B-cell lymphoma and collision tumors of five cases].
Liu J; Liu GZ; Xia L; Wang HY; Zhang XF; Liu H
Zhonghua Bing Li Xue Za Zhi; 2024 Jan; 53(1):22-28. PubMed ID: 38178742
[No Abstract] [Full Text] [Related]
10. Diagnostic Utility of ema, Vimentin and CD117 Immunohistochemical Markers in Subtyping Renal Cell Carcinoma in a Nigerian Tertiary Hospital: A 10-year Retrospective Study.
Nwadiokwu JI; Adegoke OO; Ajani MA; Okolo CA; Awosusi BL; Okebalama VC
West Afr J Med; 2023 Oct; 40(10):1035-1040. PubMed ID: 37906498
[TBL] [Abstract] [Full Text] [Related]
11. Papillary renal neoplasm with reverse polarity: a clinicopathologic study of 43 cases with a focus on the expression of KRAS signaling pathway downstream effectors.
Kim B; Lee S; Moon KC
Hum Pathol; 2023 Dec; 142():1-6. PubMed ID: 37797754
[TBL] [Abstract] [Full Text] [Related]
12. Sensitive Detection of Tumor Cells Using Protein Nanoparticles with Multiple Displays of DNA Aptamers and Bioluminescent Reporters.
Nishida K; Wang G; Kobatake E; Mie M
ACS Biomater Sci Eng; 2023 Sep; 9(9):5260-5269. PubMed ID: 37642536
[TBL] [Abstract] [Full Text] [Related]
13. Cost-effectiveness of nivolumab and ipilimumab versus pembrolizumab and axitinib in advanced renal cell carcinoma with intermediate or poor prognostic risk: a Brazilian private healthcare system perspective.
Dhanji N; Decimoni TC; Dyer MTD; May JR; van de Wetering G; Petersohn S; Nickel K; Silva A; Muniz DQB; Casagrande D Oliveira AP
J Med Econ; 2023; 26(1):1108-1121. PubMed ID: 37632452
[TBL] [Abstract] [Full Text] [Related]
14. HSF-1/miR-145-5p transcriptional axis enhances hyperthermic intraperitoneal chemotherapy efficacy on peritoneal ovarian carcinosis.
Di Agostino S; Canu V; Donzelli S; Pulito C; Sacconi A; Ganci F; Valenti F; Goeman F; Scalera S; Rollo F; Bagnato A; Diodoro MG; Vizza E; Carosi M; Rufini B; Federici O; Giofrè M; Carboni F; Muti P; Ciliberto G; Strano S; Valle M; Blandino G
Cell Death Dis; 2023 Aug; 14(8):535. PubMed ID: 37598177
[TBL] [Abstract] [Full Text] [Related]
15. Clear Cell Renal Cell Carcinoma With Syncytial-Type Multinucleated Giant Tumor Cells: A Clinicopathologic Study of 14 Cases.
Nova-Camacho LM; Sangoi AR
Int J Surg Pathol; 2024 Jun; 32(4):731-737. PubMed ID: 37525565
[TBL] [Abstract] [Full Text] [Related]
16. The PRO-RCC study: a long-term PROspective Renal Cell Carcinoma cohort in the Netherlands, providing an infrastructure for 'Trial within Cohorts' study designs.
Yildirim H; Widdershoven CV; Aarts MJ; Bex A; Bloemendal HJ; Bochove-Overgaauw DM; Hamberg P; Herbschleb KH; van der Hulle T; Lagerveld BW; van Oijen MG; Oosting SF; van Thienen JV; van der Veldt AA; Westgeest HM; Zeijdner EE; Aben KK; van den Hurk C; Zondervan PJ; Bins AD
BMC Cancer; 2023 Jul; 23(1):648. PubMed ID: 37434119
[TBL] [Abstract] [Full Text] [Related]
17. First-line therapy for adults with advanced renal cell carcinoma: a systematic review and network meta-analysis.
Aldin A; Besiroglu B; Adams A; Monsef I; Piechotta V; Tomlinson E; Hornbach C; Dressen N; Goldkuhle M; Maisch P; Dahm P; Heidenreich A; Skoetz N
Cochrane Database Syst Rev; 2023 May; 5(5):CD013798. PubMed ID: 37146227
[TBL] [Abstract] [Full Text] [Related]
18. Recurrent CYP2A6 gene mutation in biphasic hyalinizing psammomatous renal cell carcinoma: Additional support of three cases.
Ding X; Zhang W; Yu W; Li Y; Shao G; Zhang L; Zhao RC; Li X
Pathol Res Pract; 2023 May; 245():154468. PubMed ID: 37104959
[TBL] [Abstract] [Full Text] [Related]
19. [Mucinous tubular and spindle cell carcinoma of kidney: Clinicopathology and prognosis].
Shen Q; Liu YX; He Q
Beijing Da Xue Xue Bao Yi Xue Ban; 2023 Apr; 55(2):276-282. PubMed ID: 37042138
[TBL] [Abstract] [Full Text] [Related]
20. muc1 Expression Affects the Immunoflogosis in Renal Cell Carcinoma Microenvironment through Complement System Activation and Immune Infiltrate Modulation.
Lucarelli G; Netti GS; Rutigliano M; Lasorsa F; Loizzo D; Milella M; Schirinzi A; Fontana A; Di Serio F; Tamma R; Ribatti D; Battaglia M; Ranieri E; Ditonno P
Int J Mol Sci; 2023 Mar; 24(5):. PubMed ID: 36902242
[TBL] [Abstract] [Full Text] [Related]
[Next]